Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy
PHASE2CompletedINTERVENTIONAL
Enrollment
15
Participants
Timeline
Start Date
February 28, 2014
Primary Completion Date
February 28, 2015
Study Completion Date
March 31, 2015
Conditions
Chemotherapy Induced Nausea and Vomiting
Interventions
DRUG
Olanzapine
DRUG
Aprepitant
Trial Locations (1)
46202
Riley Hospital for Children at Indiana University Health, Indianapolis
All Listed Sponsors
lead
Indiana University
OTHER
NCT02097823 - Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy | Biotech Hunter | Biotech Hunter